• SENSEX 80,567.71
    409.83 (+0.51%)
  • BANKNIFTY 54,067.55
    406.55 (+0.76%)
  • Ola Electric
    70.25 123.90(%)
  • N S D L
    1,236.20 880.00(%)
  • Aditya Vision
    447.00 328.25(%)
  • Vimta Labs
    829.00 787.20(%)
  • One Mobikwik
    300.00 698.30(%)
  • Tata Steel
    168.00 170.20(%)
  • Netweb Technol.
    2,564.75 3,060.00(%)
  • Apollo Micro Sys
    306.60 298.70(%)
  • Aurobindo Pharma
    1,041.00 1,592.55(%)
  • Jai Corp
    170.15 406.00(%)
  • Moschip Tech.
    196.45 279.00(%)
  • Godfrey Phillips
    10,420.00 11,462.00(%)
  • Yes Bank
    20.38 24.40(%)
  • M & M
    3,292.60 3,430.10(%)
  • NTPC
    333.45 292.70(%)
  • TBO Tek
    1,609.20 2,000.00(%)
  • AU Small Finance
    716.05 840.95(%)
  • Larsen & Toubro
    3,606.35 3,963.00(%)
  • TCS
    3,087.75 2,992.05(%)
  • Bharat Electron
    381.05 435.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Indoco Remedies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 12579.0
  • ISIN : INE873D01024
281.75 6 (2.19%)
  • As on 03 Sep 2025 (EOD)

  • Today’s Low

    273.80

  • Today’s High

    284.10

  • Open

    275.70

  • Perv Close

    275.70

  • 52W Low

    190.00

  • 52W High

    387.55

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    2,543.27

  • Div & Yield %

    0.07

  • Book Value(₹)

    119.61

  • Debt-Equity Ratio

    2.19

  • AGM Date

    03-Sep-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.47

  • Mar.Cap (₹Cr.)

    2,543.27

  • RONW (%)

    9.07

  • ROCE (%)

    10.76

Score Board

  • Equity (₹ in Cr.)

    18.45

  • BV (₹)

    119.60

  • Sales( ₹ in Cr.)

    1,518.19

  • NP (in Cr.)

    -9.89

  • NP Var(%)

    -109.0

  • Div%

    10.0

  • CPS (₹)

    9.60

  • EPS (₹)

    -1.10

  • Traded Value (₹ in Lakhs)

    2,553.88

  • 52 Week High

    387.55

  • 52 Week Low

    190.00

  • Price BSE

    277.0

  • Price NSE

    276.00

  • Market Capital( in Cr.)

    2,553.88

  • P/C Ratio

    28.90

  • P/E Ratio

    -258.50

  • Price Vs.BV

    -1.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,518.19 1,790.81 1,666.69 1,539.72 1,240.30 1,105.99
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,518.19 1,790.81 1,666.69 1,539.72 1,240.30 1,105.99
Other Income 19.48 28.24 2.33 2.32 3.11 2.43
Stock Adjustments 32.04 14.70 -6.55 26.30 12.13 8.05
Total Income 1,569.71 1,833.75 1,662.47 1,568.34 1,255.54 1,116.47
EXPENDITURE :            
Raw Materials 475.72 561.15 514.74 483.05 366.20 338.48
Power and Fuel Cost 53.45 55.31 50.61 42.78 36.89 34.75
Employee Cost 368.74 350.55 321.15 294.95 272.88 255.32
Other Manufacturing Expenses 91.60 116.72 89.70 60.66 46.07 44.38
Selling and Administration Expenses 387.49 407.12 340.26 293.42 258.53 287.83
Miscellaneous Expenses 45.19 64.86 58.79 64.15 48.29 29.95
Employee Benefit Expenses 368.74 350.55 321.15 294.95 272.88 255.32
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,422.19 1,555.72 1,375.25 1,239.02 1,028.86 990.70
Operating Profit 147.50 278.02 287.22 329.32 226.69 125.77
Interest 56.63 36.81 25.03 14.14 22.22 26.25
Gross Profit 90.87 241.21 262.19 315.18 204.47 99.52
Depreciation 98.25 87.98 70.60 78.95 73.12 70.81
Profit Before Tax -7.38 153.23 191.59 236.23 131.35 28.71
Current Tax 0.00 32.77 55.20 93.23 38.47 3.86
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.36 3.81 -4.97 -11.52 0.48 0.60
Reported Net Profit -8.74 116.64 141.36 154.52 92.39 24.25
Extraordinary Items 1.15 8.49 -0.90 -0.31 -0.17 -0.19
Adjusted Net Profit -9.89 108.15 142.26 154.83 92.56 24.44
Adjustment below Net Profit -4.49 0.04 1.44 -5.33 -0.86 -2.41
P & L Balance brought forward 781.49 685.55 563.48 428.11 339.35 320.27
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 13.83 20.73 20.73 13.82 2.76 2.76
P & L Balance carried down 754.44 781.49 685.55 563.48 428.11 339.35
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 75.00 112.50 112.50 75.00 15.00
Dividend Per Share(Rs) 0.20 1.50 2.25 2.25 1.50 0.30
Earnings Per Share-Unit Curr -0.95 12.65 15.34 16.77 10.03 2.63
Earnings Per Share(Adj)-Unit Curr -0.95 12.65 15.34 16.77 10.03 2.63
Book Value 119.61 122.22 111.45 98.13 83.44 73.81
Book Value(Adj)-Unit Curr 119.61 122.22 111.45 98.13 83.44 73.81

Shareholding Pattern

  • Promoter Group

    58.90%

  • Public Share Holding

    41.01%

  • Custodian

    0.09%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 34,193,805 37.07 34,193,805 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 107,417 0.12 107,417 8
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 20,032,067 21.72 20,032,067 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 54,333,289 58.90 54,333,289 15
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,121,803 1.22 1,121,803 37
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 17,115,573 18.55 17,115,573 8
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 374,994 0.41 374,994 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 18,612,370 20.18 18,612,370 50
2] Non Institution
Bodies Corporate 2,255,334 2.44 2,255,334 187
Clearing Members 317 0.00 317 3
Directors of their Relatives 1,140,500 1.24 1,140,500 6
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 586,084 0.64 586,084 852
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 366,043 0.40 366,043 630
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,167,648 5.60 5,041,648 23
Individuals holding nominal share capital up to Rs. 1 lakh 9,394,302 10.18 9,144,095 31,331
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 167,211 0.18 167,211 1
Sub Total 19,215,746 20.83 18,839,539 33,063
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 86,500 0.09 86,500 1
Total Shares held by Custodians and against which Depository Receipts have been issued 86,500 0.09 86,500 1
Grand Total ( A + B + C ) 92,247,905 100.00 91,871,698 33,129

Company Background

Indoco Remedies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Indoco Remedies Ltd
  • BSE Code : 12579.0
  • ISIN : INE873D01024

  • Incorporation Year

    1947

  • Registered Office

    Indoco House 166 C S T Road
    Santacruz (East) Kalina, Mumbai,
    Maharashtra-400098

  • Telephone

    91-022-26541851-55

  • FAX

    91-022-26520787

  • Chairman

    Suresh G Kare

  • Managing Director

    Aditi Kare Panandikar

  • Company Secretary

    Ramanathan Hariharan

  • Auditor

    Gokhale & Sathe

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Indoco Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Indoco Remedies 276.85 1,536.67 1,518.19 -49.35 2.68
Abbott India 32,356.30 6,684.73 6,409.15 47.34 44.95
Astrazeneca Phar 8,937.85 1,756.92 1,716.29 121.87 32.94
P & G Health Ltd 6,321.25 944.52 934.17 34.91 40.23
Glaxosmi. Pharma 2,749.15 3,866.05 3,723.49 49.44 58.72
Cipla 1,568.95 20,029.57 19,044.85 23.45 21.40
Amrutanjan Healt 729.20 469.50 451.82 38.66 21.89
Guj. Themis Bio. 376.95 152.47 150.80 92.16 27.21
Fermenta Biotec. 328.45 442.21 430.53 10.90 17.61
Bliss GVS Pharma 159.40 703.42 667.20 23.83 9.16
Ambalal Sarabhai 32.71 19.33 4.04 17.13 2.10